1. Home
  2. RYTM vs WDFC Comparison

RYTM vs WDFC Comparison

Compare RYTM & WDFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • WDFC
  • Stock Information
  • Founded
  • RYTM 2008
  • WDFC 1953
  • Country
  • RYTM United States
  • WDFC United States
  • Employees
  • RYTM N/A
  • WDFC N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • WDFC Major Chemicals
  • Sector
  • RYTM Health Care
  • WDFC Industrials
  • Exchange
  • RYTM Nasdaq
  • WDFC Nasdaq
  • Market Cap
  • RYTM 3.1B
  • WDFC 3.4B
  • IPO Year
  • RYTM 2017
  • WDFC N/A
  • Fundamental
  • Price
  • RYTM $57.07
  • WDFC $229.70
  • Analyst Decision
  • RYTM Strong Buy
  • WDFC Buy
  • Analyst Count
  • RYTM 10
  • WDFC 2
  • Target Price
  • RYTM $66.90
  • WDFC $301.00
  • AVG Volume (30 Days)
  • RYTM 549.1K
  • WDFC 124.9K
  • Earning Date
  • RYTM 02-20-2025
  • WDFC 01-10-2025
  • Dividend Yield
  • RYTM N/A
  • WDFC 1.53%
  • EPS Growth
  • RYTM N/A
  • WDFC 2.55
  • EPS
  • RYTM N/A
  • WDFC 5.22
  • Revenue
  • RYTM $112,530,000.00
  • WDFC $603,636,000.00
  • Revenue This Year
  • RYTM $63.77
  • WDFC $7.60
  • Revenue Next Year
  • RYTM $44.91
  • WDFC $7.26
  • P/E Ratio
  • RYTM N/A
  • WDFC $44.70
  • Revenue Growth
  • RYTM 81.55
  • WDFC 9.20
  • 52 Week Low
  • RYTM $35.17
  • WDFC $211.03
  • 52 Week High
  • RYTM $68.58
  • WDFC $292.36
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 52.43
  • WDFC 34.40
  • Support Level
  • RYTM $52.71
  • WDFC $221.34
  • Resistance Level
  • RYTM $60.12
  • WDFC $235.09
  • Average True Range (ATR)
  • RYTM 2.11
  • WDFC 6.44
  • MACD
  • RYTM -0.00
  • WDFC 0.55
  • Stochastic Oscillator
  • RYTM 58.93
  • WDFC 40.36

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

About WDFC WD-40 Company

WD-40 Co manufactures and sells lubricants and cleaning products. The firm's product categories include maintenance and cleaning products. Maintenance products include the WD-40 signature brand aerosol spray lubricant as well as degreasers, rust removers, and bicycle maintenance products. Cleaning products include toilet cleaners, carpet stain removers and deodorizers, and heavy-duty hand soaps used to clean grease. The company organizes itself into three segments based on geography: Americas, Europe/Middle East/Africa, and Asia-Pacific. The majority of the company's revenue comes from the Americas segment, which includes the United States, Canada, and Latin America.

Share on Social Networks: